LNTH stock forecast
Our latest prediction for Lantheus Holdings, Inc.'s stock price was made on the Dec. 20, 2019 when the stock price was at 20.71$.
In the short term (2weeks), LNTH's stock price should underperform the market by -3.48%. During that period the price should oscillate between -6.75% and +5.26%.
In the medium term (3months), LNTH's stock price should underperform the market by -10.49%. During that period the price should oscillate between -23.69% and +13.36%.Get email alerts
About Lantheus Holdings, Inc.
Lantheus Holdings, Inc. engages in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its products are used by cardiologists, nuclear physicians, radiologists, internal medicine physicians, sonographers and technologists working in a variety of clinical settings. The firm's operates through the following geographical segments: U.S. and International. The U.S. segment produces and markets medical imaging agents and products throughout the U.S. This segment sells its products to radio pharmacies, integrated delivery networks, hospitals, clinics and group practices. The International segment operations consist of production and distribution activities in Puerto Rico and direct distribution activities in Canada. The company was founded in 1956 and is headquartered in North Billerica, MA.
At the moment the company generates 344M USD in revenues.
On its last earning announcement, the company reported a profit of 0.87$ per share.
The book value per share is 1.15$
Three months stock forecastDec. 20, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|